E Fund Management Co., Ltd. Chinook Therapeutics, Inc. Transaction History

E Fund Management Co., Ltd.

  • $1.93 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$18.66 - $38.58 $16,924 - $34,992
907 Added 8.82%
11,196 $430,000
Q1 2023

May 11, 2023
BUY
$21.53 - $26.8 $25,233 - $31,409
1,172 Added 12.86%
10,289 $238,000
Q4 2022

Feb 14, 2023
BUY
$18.63 - $27.35 $169,849 - $249,349
9,117 New
9,117 $239,000

Others Institutions Holding KDNY

# of Institutions
5
Shares Held
234K
Call Options Held
0
Put Options Held
0
View Full List

About CHINOOK THERAPEUTICS, INC.

KDNY Quotes by TradingView
  • Ticker KDNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,896,300
  • Description
  • Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...
More about KDNY
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email